Birchview Capital as of Sept. 30, 2015
Portfolio Holdings for Birchview Capital
Birchview Capital holds 42 positions in its portfolio as reported in the September 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Celgene Corporation | 51.4 | $86M | 796k | 108.17 | |
| Accelr8 Technology | 19.9 | $34M | 2.1M | 16.18 | |
| Hansen Medical | 8.5 | $14M | 3.8M | 3.76 | |
| Vermillion | 3.2 | $5.4M | 2.7M | 2.00 | |
| Metabolix | 1.7 | $2.8M | 2.3M | 1.24 | |
| EQT Corporation (EQT) | 1.6 | $2.7M | 42k | 64.78 | |
| Contrafect | 1.2 | $2.0M | 455k | 4.45 | |
| Masimo Corporation (MASI) | 0.8 | $1.4M | 37k | 38.55 | |
| Medivation | 0.8 | $1.4M | 33k | 42.49 | |
| Collegium Pharmaceutical Inc Common Stock Usd (COLL) | 0.8 | $1.3M | 59k | 22.10 | |
| Gilead Sciences (GILD) | 0.8 | $1.3M | 13k | 98.21 | |
| Southwestern Energy Company | 0.7 | $1.2M | 97k | 12.69 | |
| Biolase Technology | 0.6 | $1.1M | 1.2M | 0.90 | |
| Oncomed Pharmaceuticals | 0.6 | $974k | 59k | 16.60 | |
| Continental Resources | 0.6 | $947k | 33k | 28.98 | |
| Encana Corp | 0.5 | $852k | 132k | 6.44 | |
| Quotient | 0.5 | $757k | 58k | 13.01 | |
| Merck & Co (MRK) | 0.4 | $741k | 15k | 49.40 | |
| Quidel Corporation | 0.4 | $736k | 39k | 18.88 | |
| Sientra | 0.4 | $693k | 68k | 10.15 | |
| Aegerion Pharmaceuticals | 0.4 | $626k | 46k | 13.61 | |
| Accuray Incorporated (ARAY) | 0.4 | $602k | 120k | 5.00 | |
| Tornier Nv | 0.4 | $612k | 30k | 20.40 | |
| Cabot Oil & Gas Corporation (CTRA) | 0.3 | $459k | 21k | 21.86 | |
| Ptc Therapeutics I (PTCT) | 0.3 | $451k | 17k | 26.69 | |
| Neurocrine Biosciences (NBIX) | 0.2 | $386k | 9.7k | 39.79 | |
| Celgene Corp right 12/31/2011 | 0.2 | $384k | 238k | 1.61 | |
| Pioneer Natural Resources | 0.2 | $365k | 3.0k | 121.67 | |
| Cerus Corporation (CERS) | 0.2 | $377k | 83k | 4.54 | |
| Advaxis | 0.2 | $364k | 36k | 10.22 | |
| Merrimack Pharmaceuticals In | 0.2 | $360k | 42k | 8.51 | |
| Raptor Pharmaceutical | 0.2 | $327k | 54k | 6.06 | |
| Roka Bioscience | 0.2 | $297k | 152k | 1.95 | |
| Biogen Idec (BIIB) | 0.2 | $292k | 1.0k | 292.00 | |
| Transition Therapeutics | 0.2 | $261k | 146k | 1.79 | |
| NxStage Medical | 0.1 | $232k | 15k | 15.78 | |
| Agios Pharmaceuticals (AGIO) | 0.1 | $240k | 3.4k | 70.59 | |
| Oxford Immunotec Global | 0.1 | $207k | 15k | 13.53 | |
| Puma Biotechnology (PBYI) | 0.1 | $162k | 2.2k | 75.35 | |
| PetroQuest Energy | 0.1 | $143k | 122k | 1.17 | |
| Xencor (XNCR) | 0.1 | $150k | 12k | 12.20 | |
| Coherus Biosciences (CHRS) | 0.1 | $150k | 7.5k | 20.00 |
